• The Future of Specialty Medications: What Employer Plans Need to Know

    The pipeline for specialty and advanced therapies continues to expand. Gene therapies, targeted oncology treatment, and high-cost biologics are expected to significantly affect pharmacy benefits over the next decade. Employer-sponsored health plans should start preparing now for how they are going to handle these costs. The specialty market was $92.5 billion in 2023 and could…

  • The Rise of Medical Rebates

    Part two of a three-part series by Sam Warman Vice President at Gateway Health Partners on understanding and optimizing medical rebates. Since medical rebates began, they have grown to become essential in offsetting the costs of specialty drugs administered in a clinical setting. Historically, because the use of these specialty medications falls under a patient’s…